强烈否认做空指控 中国飞鹤(6186.HK)午后直线拉升涨近7%再创新高
中国飞鹤(6186.HK)午后开盘直线拉升,并再创历史新高17港元,现报16.88港元,涨幅6.7%,最新总市值1507.9亿港元。公司午间公告称,相比截至2019年6月30日止六个月,预期集团截至2020年6月30日止六个月的收入将大幅增长超过40%,该等增长主要得益于高端婴幼儿配方奶粉销量的大幅增长。公告还指,Blue Orca Capital 7月8日刊发对公司财务表现的指控并不准确及具误导性,董事会强烈否认该报告中的有关指控。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.